BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 19018776)

  • 1. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Cancer Sci; 2009 Feb; 100(2):248-54. PubMed ID: 19068093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between LAT1 expression and response to platinum-based chemotherapy in non-small cell lung cancer patients with postoperative recurrence.
    Kaira K; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Oriuchi N; Kanai Y; Endo M; Kondo H; Nakajima T; Yamamoto N
    Anticancer Res; 2011 Nov; 31(11):3775-82. PubMed ID: 22110199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis.
    Furuya M; Horiguchi J; Nakajima H; Kanai Y; Oyama T
    Cancer Sci; 2012 Feb; 103(2):382-9. PubMed ID: 22077314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.
    Kaira K; Oriuchi N; Otani Y; Shimizu K; Tanaka S; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Dobashi K; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
    Clin Cancer Res; 2007 Nov; 13(21):6369-78. PubMed ID: 17975149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    J Surg Oncol; 2009 Jun; 99(7):433-8. PubMed ID: 19347882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
    Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
    Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
    Toyoda M; Kaira K; Shino M; Sakakura K; Takahashi K; Takayasu Y; Tominaga H; Oriuchi N; Nikkuni O; Suzuki M; Iijima M; Tsukamoto N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Head Neck; 2015 Nov; 37(11):1569-74. PubMed ID: 24913970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.
    Haase C; Bergmann R; Fuechtner F; Hoepping A; Pietzsch J
    J Nucl Med; 2007 Dec; 48(12):2063-71. PubMed ID: 18056335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma.
    Kobayashi H; Ishii Y; Takayama T
    J Surg Oncol; 2005 Jun; 90(4):233-8. PubMed ID: 15906366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
    Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
    Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors.
    Koshi H; Sano T; Handa T; Yanagawa T; Saitou K; Nagamori S; Kanai Y; Takagishi K; Oyama T
    Pathol Int; 2015 Sep; 65(9):460-7. PubMed ID: 26134029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
    Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
    Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of L-type amino acid transporter 1 in a rat model of liver metastasis: positive correlation with tumor size.
    Tamai S; Masuda H; Ishii Y; Suzuki S; Kanai Y; Endou H
    Cancer Detect Prev; 2001; 25(5):439-45. PubMed ID: 11718450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in oral squamous cell carcinoma and its precusor lesions.
    Kim DK; Ahn SG; Park JC; Kanai Y; Endou H; Yoon JH
    Anticancer Res; 2004; 24(3a):1671-5. PubMed ID: 15274339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.
    Kaira K; Oriuchi N; Shimizu K; Ishikita T; Higuchi T; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
    Cancer Sci; 2009 Apr; 100(4):753-8. PubMed ID: 19141127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.